GCKR and metabolic dysfunction-associated steatotic liver disease: A genome-wide association analysis of a cohort including 19,381 individuals identified a strong correlation between GCKR (rs780094 variant) and a computed tomography-proven and biopsy-proven NAFLD (OR: 1.45, p = 2.59 × 10−8) [42].